Rutgers Health/Robert Wood Johnson Medical School
Radiation Oncology residency · New Brunswick, NJ · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Rutgers Health's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Rutgers Healthinstitution-wide radiation oncology research
Radiation Oncology publications from Rutgers Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
173
works per year
29th of 47 radiation oncology residency programs
+12.3%
2-year growth
22nd of 47 radiation oncology residency programs
19.9%
in top 10% of field (works before 2025)
31st of 47 radiation oncology residency programs
38.8%
cited above world average
32nd of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 696Radiology, Nuclear Medicine and Imaging · 143
Radiation Oncology research topics at Rutgers Health
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 109
- Pancreatic and Hepatic Oncology Research 89
- Cancer survivorship and care 76
- CAR-T cell therapy research 74
- Colorectal Cancer Treatments and Studies 49
- Global Cancer Incidence and Screening 47
- Cutaneous Melanoma Detection and Management 42
- Radiomics and Machine Learning in Medical Imaging 26
Most cited at Rutgers Health since 2024
All radiation oncology papers there on OpenAlex
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 555
- CAR T Cells and T-Cell Therapies for CancerJennifer N. Brudno et al. · JAMA · 2024 · PubMed · cited 388
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 91
- Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerCaitlin A. McIntyre et al. · Cancer Cell · 2024 · PubMed · cited 85
- Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancerRay Pillai et al. · Science Advances · 2024 · PubMed · cited 79
- Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancerLinda Bojmar et al. · Nature Medicine · 2024 · PubMed · cited 68
- Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005Kyndra S. Higgins et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · cited 57
- The BTLA–HVEM axis restricts CAR T cell efficacy in cancerPuneeth Guruprasad et al. · Nature Immunology · 2024 · PubMed · cited 52
- Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic MalignanciesAyrton Bangolo et al. · Cancers · 2025 · PubMed · cited 47